Jeff Johnson
Stock Analyst at Baird
(4.66)
# 200
Out of 5,146 analysts
154
Total ratings
59.05%
Success rate
28.9%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Upgrades: Outperform | $78 → $100 | $81.91 | +22.09% | 11 | Feb 23, 2026 | |
| BBNX Beta Bionics | Maintains: Neutral | $28 → $14 | $12.89 | +8.61% | 3 | Feb 18, 2026 | |
| TNDM Tandem Diabetes Care | Upgrades: Outperform | $18 → $30 | $26.01 | +15.34% | 17 | Dec 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $117 → $100 | $99.85 | +0.15% | 15 | Dec 16, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $85 → $98 | $83.47 | +17.41% | 19 | Dec 5, 2025 | |
| ALC Alcon | Maintains: Outperform | $95 → $98 | $86.27 | +13.60% | 11 | Nov 13, 2025 | |
| DXCM DexCom | Maintains: Outperform | $112 → $90 | $73.16 | +23.02% | 15 | Sep 26, 2025 | |
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $29.59 | -22.27% | 10 | May 27, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $384.03 | +5.46% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $188.05 | +46.77% | 18 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $248.12 | -4.08% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $22.32 | +213.62% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $13.96 | +336.96% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $12.80 | +423.44% | 6 | Feb 18, 2022 |
Henry Schein
Feb 23, 2026
Upgrades: Outperform
Price Target: $78 → $100
Current: $81.91
Upside: +22.09%
Beta Bionics
Feb 18, 2026
Maintains: Neutral
Price Target: $28 → $14
Current: $12.89
Upside: +8.61%
Tandem Diabetes Care
Dec 16, 2025
Upgrades: Outperform
Price Target: $18 → $30
Current: $26.01
Upside: +15.34%
Zimmer Biomet Holdings
Dec 16, 2025
Downgrades: Neutral
Price Target: $117 → $100
Current: $99.85
Upside: +0.15%
The Cooper Companies
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $98
Current: $83.47
Upside: +17.41%
Alcon
Nov 13, 2025
Maintains: Outperform
Price Target: $95 → $98
Current: $86.27
Upside: +13.60%
DexCom
Sep 26, 2025
Maintains: Outperform
Price Target: $112 → $90
Current: $73.16
Upside: +23.02%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $29.59
Upside: -22.27%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $384.03
Upside: +5.46%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $188.05
Upside: +46.77%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $248.12
Upside: -4.08%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $22.32
Upside: +213.62%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $13.96
Upside: +336.96%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $12.80
Upside: +423.44%